Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Bromelain vs Corticosteroids in RAS
NCT06993337Phase 2Not yet recruiting
- Sponsor
- Cairo University
- Start
- Jun 2025
- Primary completion
- May 2026
- Modality
- Replacement Enzymes
01
Overview
A Phase 2 trial of bromelain in recurrent aphthous stomatitis (RAS), sponsored by Cairo University. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
bromelain
03
Conditions
recurrent aphthous stomatitis (RAS)
Beyond the preview
Go deeper on NCT06993337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06993337.